Status:

RECRUITING

Cannabis-Tobacco Co-Use Treatment Study

Lead Sponsor:

Medical University of South Carolina

Collaborating Sponsors:

National Cancer Institute (NCI)

Conditions:

Tobacco Use Disorder

Tobacco Use Cessation

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The purpose of the RECLAIM study is to evaluate the effectiveness of varenicline (sometimes known as Chantix) compared to placebo (an inactive substance) for the treatment of cigarettes and cannabis (...

Detailed Description

Tobacco-cannabis co-use results in established harms, yet there are currently no recommended treatment strategies for co-use. The scientific premise of this proposal is based on work conducted by our ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Ages 18 and over (no upper age limit)
  • Must smoke at least 5 tobacco cigarettes per day on at least 20 out of the past 30 days for the past 3 months
  • Must express interest in quitting tobacco
  • Must express interest in cannabis reduction and/or cessation
  • Must submit a positive instant-read test for cotinine and cannabis prior to enrollment
  • Must self-report cannabis use (THC-dominant products) on at 3 days per week out of the past 30 days
  • Must be willing to take varenicline or placebo for 12 weeks
  • Must reside in South Carolina
  • Exclusion criteria:
  • Any significant or acutely unstable medical, psychiatric, or substance use problem (including clinically significant disorders) that would contraindicate research, interfere with safety, compromise data integrity, or preclude consistent study participation
  • Pregnant or trying to become pregnant
  • Use of medications with smoking cessation efficacy
  • Regular use of e-cigarettes or other tobacco products (\<10 days in the past month)
  • Self-reported use of cannabis exclusively for medical purposes

Exclusion

    Key Trial Info

    Start Date :

    May 6 2025

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ESTIMATED

    End Date :

    January 1 2029

    Estimated Enrollment :

    200 Patients enrolled

    Trial Details

    Trial ID

    NCT06883162

    Start Date

    May 6 2025

    End Date

    January 1 2029

    Last Update

    May 8 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Medical University of South Carolina - Charleston

    Charleston, South Carolina, United States, 29403